Gastric cancer (GC) is one of the most common malignant cancers worldwide. Metastasis leads to poor prognoses in GC patients in advanced stages. Our previous studies have demonstrated that JWA functions as a tumour suppressor and that low expression of JWA in GC tissues is significantly correlated with shorter overall survival (OS) as well as with advanced clinicopathologic features in patients. However, the mechanism of dysregulation of JWA in cancers is not clear. In the present study, we found that an E3 ubiquitin ligase, RNF185, directly interacted with JWA and promoted its ubiquitination at the K158 site, resulting in subsequent degradation. Moreover, the protein level of RNF185 was negatively correlated with JWA in tumour tissues from GC patients. High RNF185 expression was significantly correlated with shorter OS. Additionally, increased RNF185 expression facilitated GC cell migration in vitro and promoted GC metastasis in vivo by downregulating JWA expression. However, this effect was reversed by replenishment of JWA. In conclusion, our findings highlight the following: (1) RNF185 promotes GC metastasis by mediating JWA degradation via a ubiquitin-proteasome pathway; (2) the K158 site of JWA is essential for its ubiquitination in GC cells. These findings suggest that RNF185 is a novel candidate prognostic marker and potential therapeutic target for GC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bbadis.2018.02.013 | DOI Listing |
BMC Prim Care
December 2024
Department of Public Health and Primary Care, Leiden University Medical Center, Hippocratespad 21, Leiden, 2333 ZD, The Netherlands.
Background: The COVID-19 lockdown had profound effects on society and healthcare. Cardiology departments reported declines in chest pain evaluations and acute coronary syndrome (ACS) diagnoses. However, the pattern of chest pain in primary care is not clear yet.
View Article and Find Full Text PDFPurpose: This descriptive analysis evaluated the 2022 assisted reproductive technology (ART) data collected by the Japan Society of Obstetrics and Gynecology registry.
Methods And Results: In 2022 (cutoff date 30 November 2023), 634 of 635 registered ART facilities participated; 602 implemented ART treatment, with 543 630 registered cycles and 77 206 neonates (9.1% and 10.
Arthroscopy
December 2024
Commons Clinic (J.J.W., P.N.R.); Warren Alpert Brown School of Medicine (J.J.W., A.J.Y., R.Y.H.).
Medical research within areas of deep learning, particularly in computer vision for medical imaging, has shown promise over the past decade with an increasing volume of technical papers published in orthopaedics related to imaging artificial intelligence (AI). However, as more tools and models are developed and deployed, it is easy for clinicians to get overwhelmed with the different types of models, leaving "artificial intelligence" as an empty buzzword where true value can be unclear. As with surgery, the techniques of deep learning require thoughtful application and cannot follow a one-size-fits-all approach as different problems require differential levels of technical complexity with model application.
View Article and Find Full Text PDFPeerJ
December 2024
Division of Hepatobiliary Surgery and Liver Transplantation, Seoul, Republic of South Korea.
Background & Aims: The global pandemic caused by the highly contagious SARS-CoV-2 virus led to the emergency approval of COVID-19 vaccines to reduce rising morbidity and mortality. However, limited research exists on evaluating the impact of these vaccines on immunocompromised individuals, such as recipients of living donor liver transplantation, highlighting the need for further studies to better understand their effectiveness in this specific population.
Methods: From June 2021, we followed up on the effectiveness of the vaccine for patients taking immunosuppressive drugs after living-donor liver transplantation (LDLT).
Lancet Oncol
January 2025
Department of Thoracic Oncology and Surgery, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China; Department of Thoracic Oncology and Surgery, Hengqin Hospital, The First Affiliated Hospital of Guangzhou Medical University, Hengqin, China. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!